These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21455420)

  • 1. Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial.
    Chatterjee S; Biswas T; Dutta A; Sengupta G; Mitra A; Kundu S
    Indian J Pharmacol; 2011 Feb; 43(1):40-4. PubMed ID: 21455420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
    Wilson R; Schentag JJ; Ball P; Mandell L;
    Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness and safety of cefpodoxime and ciprofloxacin in acute exacerbation of chronic suppurative otitis media: A randomized, open-labeled, phase IV clinical trial.
    Ghosh A; Jana U; Khaowas A; Das S; Mandal A; Das N
    J Pharmacol Pharmacother; 2012 Oct; 3(4):320-4. PubMed ID: 23326103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
    Sethi S; Fogarty C; Fulambarker A
    Respir Med; 2004 Aug; 98(8):697-707. PubMed ID: 15303633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
    Wilson R; Langan C; Ball P; Bateman K; Pypstra R;
    Respir Med; 2003 Mar; 97(3):242-9. PubMed ID: 12645831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
    Zhang L; Wang R; Falagas ME; Chen LA; Liu YN
    Chin Med J (Engl); 2012 Feb; 125(4):687-95. PubMed ID: 22490497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK; Triller DM; Yong CS; Lodise TP
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of gemifloxacin: results from the GLOBE study.
    Halpern MT; Palmer CS; Zodet M; Kirsch J
    Am J Health Syst Pharm; 2002 Jul; 59(14):1357-65. PubMed ID: 12132563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections.
    Ball P; File TM; Twynholm M; Henkel T
    Int J Antimicrob Agents; 2001 Jul; 18(1):19-27. PubMed ID: 11463522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
    Geddes AM
    Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis.
    Jivcu C; Gotfried M
    Int J Chron Obstruct Pulmon Dis; 2009; 4():291-300. PubMed ID: 19684863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
    Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
    Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of recovery of health status following an infective exacerbation of chronic bronchitis.
    Spencer S; Jones PW;
    Thorax; 2003 Jul; 58(7):589-93. PubMed ID: 12832673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemifloxacin for the treatment of respiratory tract infections: in vitro susceptibility, pharmacokinetics and pharmacodynamics, clinical efficacy, and safety.
    Bhavnani SM; Andes DR
    Pharmacotherapy; 2005 May; 25(5):717-40. PubMed ID: 15899734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.
    Hooton TM; Roberts PL; Stapleton AE
    JAMA; 2012 Feb; 307(6):583-9. PubMed ID: 22318279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H; File TM; Mandell L; Ball P; Pypstra R; Thomas M;
    Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
    File T; Schlemmer B; Garau J; Lode H; Lynch S; Young C
    J Chemother; 2000 Aug; 12(4):314-25. PubMed ID: 10949981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of chest X-ray findings and other parameters in acute exacerbation of chronic bronchitis in Japan and the West.
    Watanabe A; Kohno S; Niki Y; Saito A
    J Infect Chemother; 2001 Mar; 7(1):37-44. PubMed ID: 11406755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.